ALLT vs AVGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Allot Ltd. (ALLT) exhibits a Piotroski F-Score of 4/9, indicating weak financial health and signaling potential distress despite strong growth metrics. The absence of an Altman Z-Score raises concern about bankruptcy risk, particularly given inconsistent earnings and a history of losses. While the company shows impressive revenue and earnings growth (14% YoY and 877% YoY EPS growth), these are driven by volatile, non-recurring gains and a recent sharp decline in Q/Q EPS growth. The stock trades at a high forward P/E of 15.54 and a current P/E of 80.62, suggesting overvaluation relative to its modest profitability and Graham Number of $2.05. Despite a strong analyst consensus of 'strong_buy', the technical trend is bearish and insider sentiment is neutral, underscoring caution.
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
Compare Another Pair
Related Comparisons
ALLT vs AVGO: Head-to-Head Comparison
This page compares Allot Ltd. (ALLT) and Broadcom Inc. (AVGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.